Fatty liver disease (MASLD/MASH) trials in Jordan

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Where

  Amman, Jordan

  Age

  18 years and over

  People

  1,590 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632457 · EU 2024-513741-36-00
• Phase 3Taking people
  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Where

  Amman, Irbid, Jordan

  Age

  18 years and over

  People

  1,800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632444 · EU 2024-513739-25-00